Unichem Laboratories Limited

BSE: 506690 NSE: UNICHEMLAB
Unichem Laboratories Limited - pharma in Kandivali West, Maharashtra, India. FY 2026 financials and compliance.
CIN L99999MH1962PLC012451 Incorporated 22 August 1962 ROC Mumbai HQ Kandivali West, Maharashtra, India
Active Listed - NSE: UNICHEMLAB · BSE: 506690 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹2,201.85 Cr
▲ 4.31% YoY
EBITDA · FY 2026
₹247.23 Cr
▼ 17.64% YoY
Net profit · FY 2026
₹252.84 Cr
▲ 83.86% YoY
Authorised capital
₹50 Cr
Registered with MCA
Paid-up capital
₹14.08 Cr
Issued & subscribed
Open charges
₹236 Cr
Satisfied ₹249.07 Cr
Company age
64 yrs
Est. 1962
Employees · EPFO
3,635
Latest available

About Unichem Laboratories Limited

Data last updated: 18 March 2026

Unichem Laboratories Limited is a public limited company based in Kandivali West, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 22 August 1962, the company has been in operation for over 64 years.

Registered with ROC Mumbai under CIN L99999MH1962PLC012451. Listed on BSE: 506690 and NSE: UNICHEMLAB.

Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹14.08 Cr. It is led by directors including Pranay Premchand Godha and Pabitrakumar Kalipada Bhattacharyya.

Last AGM: 04 August 2025. Financial statements filed for year ended 31 March 2025. Office: 47 Kandivli Industrial Estate, Kandivali West, Maharashtra, India – 400067.

As per the financials filed for FY 2025, the company reported a revenue of ₹2,146.29 Cr, a growth of 18% compared to the previous year.

The company has a workforce of approximately 3,635 employees as per the latest available data.

The company is associated with 2 brands - Unichem Laboratories, Unichem Labs. As per MCA filings, the company has open charges of ₹236 Cr and satisfied charges of ₹249.07 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unichemlabs.com.

Company Details of Unichem Laboratories Limited
CIN L99999MH1962PLC012451
Registration Number 012451
Incorporation Date 22 August 1962
ROC Mumbai
Listing Status Listed (BSE: 506690, NSE: UNICHEMLAB)
Company Status Active
Date of Last AGM 04 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Pabitrakumar Kalipada Bhattacharyya Managing Director Pranay Premchand Godha Director Prakash Amrut Mody Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    unichemlabs.com
  • Social Media
  • Registered Address
    47 Kandivli Industrial Estate, Kandivali West, Maharashtra, India – 400067
  • Industry
    Pharma, API Manufacturers, Drug Formulation & Development
Company report
Unichem Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Unichem Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Unichem Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Unichem Laboratories Limited

Unichem Laboratories Limited operates two associated brands: Unichem Laboratories and Unichem Labs. These brands represent Unichem Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Unichem Labs
Branded formulations, APIs, and biosimilars are manufactured. unichemlabs.com
Unichem Laboratories
Pharmaceutical formulations, active pharmaceutical ingredients manufacturing, and related services in India. unichem-hrp.com

Business Activity of Unichem Laboratories Limited

Unichem Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Unichem Laboratories Limited

Unichem Laboratories Limited is audited by N A Shah Associates LLP (ICAI peer reviewed, certificate valid till 2028-08-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
N A Shah Associates LLP (ICAI peer reviewed, certificate valid till 2028-08-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Unichem Laboratories Limited

Unichem Laboratories Limited is currently managed by 9 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Pranay Premchand Godha
Also directs: Xgrow Traders Llp, Xbees Traders Llp, Ipca Laboratories Limited and 2 more
Director 10 Aug 2023 2 Years 10 Months Current
Pabitrakumar Kalipada Bhattacharyya
Also directs: Krebs Biochemicals And Industries Limited
Managing Director 10 Aug 2023 2 Years 10 Months Current
Prakash Amrut Mody
Also directs: Elemage Wellness Llp, Prajay Advisors Llp, Spm International Private Limited
Director 01 Jul 2008 18 Years 0 Months Current
Arun Todarwal Lalchand
Also directs: Arun Todarwal & Associates Llp, Arun Todarwal & Co Llp, Laxmi Organic Industries Limited and 5 more
Director 05 Feb 2024 2 Years 5 Months Current
Priti Puri Director 21 Mar 2023 3 Years 3 Months Current
Anand Trimbak Kusre
Also directs: Entrepreneurship Development Center, Coep's Bhau Institute Of Innovation Entrepreneurship And Leadership, Dharwad Research And Technology Incubator Foundation
Director 05 Feb 2024 2 Years 5 Months Current
Showing 6 of 9 current directors. View all directors

Financials of Unichem Laboratories Limited FY 2026 filings available

Unichem Laboratories Limited reported revenue of ₹2,201.85 Cr (up 4.31% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹2,201.85 Cr ▲ 4.31%
Profit · FY 2026
₹252.84 Cr ▲ 83.86%
EBITDA · FY 2026
₹247.23 Cr ▼ 17.64%
Revenue₹ Cr · Consolidated01,0002,0003,000FY 2020: ₹1,211 Cr1,211FY 2020FY 2021: ₹1,235 Cr · +2% YoY1,235+2%FY 2021FY 2022: ₹1,270 Cr · +2.8% YoY1,270+2.8%FY 2022FY 2023: ₹1,343 Cr · +5.8% YoY1,343+5.8%FY 2023FY 2024: ₹1,705 Cr · +26.9% YoY1,705+26.9%FY 2024FY 2025: ₹2,111 Cr · +23.8% YoY2,111+23.8%FY 2025FY 2026: ₹2,202 Cr · +4.3% YoY2,202+4.3%FY 2026
Net Profit₹ Cr · Consolidated-300-200-1000100200300FY 2020: ₹60 Cr (loss)-60.2FY 2020FY 2021: ₹34 Cr · +157% YoY34.3+157%FY 2021FY 2022: ₹33 Cr · -3.7% YoY33.1-3.7%FY 2022FY 2023: ₹202 Cr (loss) · -711.7% YoY-202FY 2023FY 2024: ₹70 Cr (loss) · +65.2% YoY-70.5FY 2024FY 2025: ₹138 Cr · +295.1% YoY138+295.1%FY 2025FY 2026: ₹253 Cr · +83.9% YoY253+83.9%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0200400600Q1'25: ₹446 Cr · +5.5% YoY446+5.5%Q1'25Q2'25: ₹462 Cr · +11.2% YoY462+11.2%Q2'25Q3'25: ₹533 Cr · +22.7% YoY533+22.7%Q3'25Q4'25: ₹587 Cr · +36% YoY587+36%Q4'25Q1'26: ₹527 Cr · +18% YoY527+18%Q1'26Q2'26: ₹579 Cr · +25.3% YoY579+25.3%Q2'26Q3'26: ₹521 Cr · -2.2% YoY521-2.2%Q3'26Q4'26: ₹575 Cr · -2.1% YoY575-2.1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹2,201.85 Cr ₹2,110.97 Cr ₹1,704.89 Cr ₹1,343.02 Cr ₹1,269.83 Cr ₹1,235.14 Cr ₹1,210.62 Cr
Other Income ₹63.06 Cr ₹35.32 Cr ₹31.6 Cr ₹38.52 Cr ₹47.51 Cr ₹50.19 Cr ₹91.31 Cr
Total Income ₹2,264.91 Cr ₹2,146.29 Cr ₹1,736.49 Cr ₹1,381.54 Cr ₹1,317.34 Cr ₹1,285.32 Cr ₹1,301.93 Cr
Cost of Materials Consumed ₹768.83 Cr ₹888.24 Cr ₹742.8 Cr ₹532.2 Cr ₹456.01 Cr ₹466.99 Cr ₹421.43 Cr
Purchases of Stock-in-Trade ₹231.51 Cr ₹175.78 Cr ₹91.09 Lakh ₹1.53 Cr ₹1.35 Cr ₹53.52 Lakh ₹1.04 Cr
Changes in Inventories ₹20.21 Cr -₹200.35 Cr -₹79.09 Cr ₹17.2 Cr -₹41.53 Cr -₹88.14 Cr -₹35.76 Cr
Employee Benefit Expense ₹396.63 Cr ₹402.21 Cr ₹393.06 Cr ₹356.41 Cr ₹330.49 Cr ₹306.97 Cr ₹273.28 Cr
Finance Costs ₹31.59 Cr ₹21.03 Cr ₹22.66 Cr ₹17.31 Cr ₹6.11 Cr ₹5.12 Cr ₹7.85 Cr
Depreciation & Amortisation ₹125.12 Cr ₹124.56 Cr ₹113.24 Cr ₹113.44 Cr ₹91.17 Cr ₹84.36 Cr ₹81.67 Cr
Other Expenses ₹600.5 Cr ₹580.23 Cr ₹546.96 Cr ₹481.24 Cr ₹450.72 Cr ₹457.67 Cr ₹601.44 Cr
Total Expenses ₹2,174.39 Cr ₹1,991.7 Cr ₹1,740.55 Cr ₹1,519.33 Cr ₹1,294.31 Cr ₹1,233.5 Cr ₹1,350.96 Cr
Profit Before Exceptional Items & Tax ₹90.52 Cr ₹154.59 Cr -₹4.06 Cr -₹137.8 Cr ₹23.03 Cr ₹51.82 Cr -₹49.02 Cr
Exceptional Items ₹201.86 Cr ₹0 -₹57.61 Cr -₹38.57 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹292.38 Cr ₹154.59 Cr -₹61.67 Cr -₹176.36 Cr ₹23.03 Cr ₹51.82 Cr -₹49.02 Cr
Total Tax Expense ₹39.54 Cr ₹17.07 Cr ₹8.81 Cr ₹25.86 Cr -₹11.09 Cr ₹17.15 Cr ₹11.97 Cr
Net Profit ₹252.84 Cr ₹137.52 Cr -₹70.47 Cr -₹202.23 Cr ₹33.06 Cr ₹34.32 Cr -₹60.18 Cr
  attributable to Owners ₹0 ₹0 ₹0 - ₹0 ₹0 ₹0
  attributable to NCI ₹0 ₹0 ₹0 - ₹0 ₹0 ₹0
Other Comprehensive Income ₹11.99 Cr -₹6.97 Cr -₹5.47 Cr ₹45.92 Cr ₹53.75 Cr ₹16.39 Cr ₹3.06 Cr
Total Comprehensive Income ₹264.83 Cr ₹130.55 Cr -₹75.95 Cr -₹156.3 Cr ₹86.81 Cr ₹50.72 Cr -₹57.13 Cr
EBITDA (computed) ₹247.23 Cr ₹300.18 Cr ₹131.84 Cr -₹7.04 Cr ₹120.3 Cr ₹141.3 Cr ₹40.49 Cr
Basic EPS ₹35.91 ₹19.53 ₹-10.01 ₹-28.72 ₹4.70 ₹4.88 ₹-8.55
Diluted EPS ₹35.85 ₹19.47 ₹-10.01 ₹-28.72 ₹4.68 ₹4.88 ₹-8.55
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹3,737.44 Cr ₹3,569.4 Cr ₹3,169.34 Cr ₹3,193.05 Cr
Non-current Assets ₹1,536.85 Cr ₹1,531.45 Cr ₹1,471.84 Cr ₹1,601.17 Cr
Current Assets ₹2,197.34 Cr ₹2,029.47 Cr ₹1,694.16 Cr ₹1,588.47 Cr
Property, Plant & Equipment ₹1,203.7 Cr ₹1,279.32 Cr ₹1,194.43 Cr ₹1,255.12 Cr
Inventories ₹974.97 Cr ₹988.74 Cr ₹704.68 Cr ₹625.23 Cr
Trade Receivables ₹828.58 Cr ₹778.81 Cr ₹610.4 Cr ₹588.62 Cr
Cash & Equivalents ₹289.48 Cr ₹89.58 Cr ₹150.91 Cr ₹183.75 Cr
Equity (Net Worth) ₹2,717.44 Cr ₹2,450.59 Cr ₹2,362.42 Cr ₹2,435.3 Cr
Equity Share Capital ₹14.08 Cr ₹14.08 Cr ₹14.08 Cr ₹14.08 Cr
Borrowings (Non-current) ₹39.12 Cr ₹60.81 Cr ₹38.22 Cr ₹63.65 Cr
Borrowings (Current) ₹429.66 Cr ₹369.16 Cr ₹180.93 Cr ₹233.74 Cr
Total Debt (computed) ₹468.78 Cr ₹429.97 Cr ₹219.15 Cr ₹297.39 Cr
Current Liabilities ₹885.94 Cr ₹991.97 Cr ₹707.88 Cr ₹639.6 Cr
Total Liabilities ₹1,020 Cr ₹1,118.81 Cr ₹806.93 Cr ₹757.74 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹3.64 Cr -₹7.02 Cr ₹16.69 Cr -₹85.09 Cr -₹259.61 Cr
Investing Cash Flow ₹192.06 Cr -₹241.23 Cr ₹50.4 Cr ₹202.81 Cr ₹100.12 Cr
Financing Cash Flow ₹1.86 Cr ₹183.76 Cr -₹106.31 Cr -₹81.3 Cr ₹191.23 Cr
Capital Expenditure ₹123.04 Cr ₹137.36 Cr ₹22.55 Cr ₹44.32 Cr ₹127 Cr
Free Cash Flow (computed) -₹119.4 Cr -₹144.38 Cr -₹5.85 Cr -₹129.41 Cr -₹386.61 Cr
Dividends Paid ₹0 ₹34 Lakh ₹21.35 Lakh ₹28.25 Cr ₹28.36 Cr
Net Change in Cash ₹199.9 Cr -₹65.17 Cr -₹32.84 Cr ₹38.18 Cr ₹31.74 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹575.12 Cr ₹521.17 Cr ₹578.96 Cr ₹526.6 Cr ₹587.18 Cr ₹533.09 Cr ₹462.16 Cr ₹446.43 Cr ₹431.7 Cr ₹434.38 Cr ₹415.63 Cr ₹423.19 Cr
Other Income ₹23.47 Cr ₹11.8 Cr ₹20.97 Cr ₹6.82 Cr ₹9.25 Cr ₹13.62 Cr ₹8.79 Cr ₹3.86 Cr ₹6.15 Cr ₹11.28 Cr ₹5.54 Cr ₹8.63 Cr
Total Income ₹598.59 Cr ₹532.97 Cr ₹599.93 Cr ₹533.42 Cr ₹596.43 Cr ₹546.71 Cr ₹470.95 Cr ₹450.29 Cr ₹437.85 Cr ₹445.66 Cr ₹421.16 Cr ₹431.82 Cr
Cost of Materials Consumed ₹184.03 Cr ₹174.26 Cr ₹193.06 Cr ₹217.48 Cr ₹275.31 Cr ₹175.05 Cr ₹210.29 Cr ₹208.06 Cr ₹197.67 Cr ₹193.92 Cr ₹174.94 Cr ₹176.27 Cr
Purchases of Stock-in-Trade ₹91.81 Cr ₹48.93 Cr ₹39.76 Cr ₹51.01 Cr ₹33.48 Cr ₹63.43 Cr ₹15.2 Cr ₹27.95 Lakh ₹21.21 Lakh ₹21.28 Lakh ₹24.22 Lakh ₹24.38 Lakh
Changes in Inventories -₹7.82 Cr ₹13.91 Cr ₹37.56 Cr -₹23.44 Cr -₹44.22 Cr -₹46.96 Cr -₹51.01 Cr -₹47.76 Cr -₹31 Cr -₹27.65 Cr -₹12.38 Cr -₹8.07 Cr
Employee Benefit Expense ₹92.85 Cr ₹99.27 Cr ₹100.13 Cr ₹107.42 Cr ₹96.47 Cr ₹101.74 Cr ₹98.81 Cr ₹98.49 Cr ₹99.42 Cr ₹98.11 Cr ₹96.72 Cr ₹98.81 Cr
Finance Costs ₹9.39 Cr ₹7.42 Cr ₹8.24 Cr ₹6.54 Cr ₹5.46 Cr ₹6.75 Cr ₹4.79 Cr ₹4.03 Cr ₹4.59 Cr ₹5.58 Cr ₹6.73 Cr ₹5.76 Cr
Depreciation & Amortisation ₹30.61 Cr ₹31.25 Cr ₹31.47 Cr ₹31.79 Cr ₹29.69 Cr ₹30.54 Cr ₹28.54 Cr ₹28.33 Cr ₹27.16 Cr ₹27.86 Cr ₹29.45 Cr ₹28.77 Cr
Other Expenses ₹166.57 Cr ₹140.02 Cr ₹142.27 Cr ₹151.64 Cr ₹142.44 Cr ₹154.31 Cr ₹131.34 Cr ₹143.87 Cr ₹140.04 Cr ₹131.66 Cr ₹147.34 Cr ₹127.92 Cr
Total Expenses ₹567.44 Cr ₹515.06 Cr ₹552.49 Cr ₹542.44 Cr ₹538.63 Cr ₹484.86 Cr ₹437.96 Cr ₹435.3 Cr ₹438.1 Cr ₹429.7 Cr ₹443.05 Cr ₹429.7 Cr
Profit Before Exceptional Items & Tax ₹31.15 Cr ₹17.91 Cr ₹47.44 Cr -₹9.02 Cr ₹57.8 Cr ₹61.85 Cr ₹32.99 Cr ₹15 Cr -₹24.6 Lakh ₹15.95 Cr -₹21.88 Cr ₹2.12 Cr
Exceptional Items -₹12.36 Cr ₹275.52 Cr -₹58.26 Cr ₹0 ₹0 ₹0 ₹0 ₹0 -₹125.62 Cr ₹68.01 Cr ₹0 ₹0
Profit Before Tax ₹18.79 Cr ₹293.43 Cr -₹10.82 Cr -₹9.02 Cr ₹57.8 Cr ₹61.85 Cr ₹32.99 Cr ₹15 Cr -₹125.87 Cr ₹83.97 Cr -₹21.88 Cr ₹2.12 Cr
Total Tax Expense ₹7.88 Cr ₹29.14 Cr ₹1.07 Cr ₹1.45 Cr ₹4.83 Cr ₹4 Cr ₹2.5 Cr ₹5.74 Cr ₹3.44 Cr -₹2.22 Lakh ₹2.61 Cr ₹2.78 Cr
Net Profit ₹10.91 Cr ₹264.29 Cr -₹11.89 Cr -₹10.47 Cr ₹52.97 Cr ₹57.85 Cr ₹30.49 Cr ₹9.26 Cr -₹129.31 Cr ₹83.99 Cr -₹24.49 Cr -₹66.83 Lakh
  attributable to Owners ₹0 ₹0 ₹0 ₹0 ₹0 - - ₹0 ₹0 - ₹0 -
  attributable to NCI ₹0 ₹0 ₹0 ₹0 ₹0 - - ₹0 ₹0 - ₹0 -
Other Comprehensive Income ₹9.16 Cr -₹2.07 Cr ₹1.85 Cr ₹3.05 Cr -₹6.27 Cr ₹1.86 Cr -₹2.82 Cr ₹28.66 Lakh -₹71.22 Lakh -₹1.6 Cr -₹64.81 Lakh -₹2.51 Cr
Total Comprehensive Income ₹20.07 Cr ₹262.22 Cr -₹10.04 Cr -₹7.42 Cr ₹46.7 Cr ₹59.71 Cr ₹27.67 Cr ₹9.54 Cr -₹130.02 Cr ₹82.39 Cr -₹25.14 Cr -₹3.18 Cr
EBITDA (computed) ₹71.15 Cr ₹56.58 Cr ₹87.15 Cr ₹29.31 Cr ₹92.95 Cr ₹99.14 Cr ₹66.32 Cr ₹47.36 Cr ₹31.5 Cr ₹49.39 Cr ₹14.3 Cr ₹36.65 Cr
Basic EPS ₹1.55 ₹37.54 ₹-1.69 ₹-1.49 ₹7.52 ₹8.22 ₹4.34 ₹1.31 ₹-18.37 ₹11.93 ₹-3.48 ₹-0.09
Diluted EPS ₹1.55 ₹37.47 ₹-1.69 ₹-1.49 ₹7.50 ₹8.19 ₹4.32 ₹1.31 ₹-18.36 ₹11.92 ₹-3.48 ₹-0.09
Latest 12 quarters shown of 25 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹1,412.29 Cr ₹1,735.7 Cr ₹1,442.17 Cr ₹1,072.43 Cr ₹942.93 Cr ₹1,123.97 Cr ₹904.89 Cr
Other Income ₹62.9 Cr ₹40.83 Cr ₹30.39 Cr ₹41.85 Cr ₹42.07 Cr ₹47.37 Cr ₹99.17 Cr
Total Income ₹1,475.19 Cr ₹1,776.53 Cr ₹1,472.55 Cr ₹1,114.28 Cr ₹984.99 Cr ₹1,171.34 Cr ₹1,004.06 Cr
Cost of Materials Consumed ₹671.59 Cr ₹829.77 Cr ₹716.92 Cr ₹500.34 Cr ₹434.92 Cr ₹449.14 Cr ₹400.21 Cr
Purchases of Stock-in-Trade ₹1.05 Cr ₹85 Lakh ₹91.09 Lakh ₹1.53 Cr ₹1.35 Cr ₹53.52 Lakh ₹1.04 Cr
Changes in Inventories -₹7.28 Cr -₹33.33 Cr -₹26.36 Cr ₹22.01 Cr -₹52.79 Cr -₹16.73 Cr -₹18.5 Cr
Employee Benefit Expense ₹277.22 Cr ₹287.51 Cr ₹283.14 Cr ₹270.86 Cr ₹250.79 Cr ₹234.04 Cr ₹205.16 Cr
Finance Costs ₹11.8 Cr ₹7.62 Cr ₹10.42 Cr ₹9.38 Cr ₹2.07 Cr ₹1.3 Cr ₹1.28 Cr
Depreciation & Amortisation ₹119.03 Cr ₹108.41 Cr ₹105.46 Cr ₹105.98 Cr ₹83.19 Cr ₹75.89 Cr ₹71.09 Cr
Other Expenses ₹419.35 Cr ₹397.02 Cr ₹416.63 Cr ₹370.61 Cr ₹352.21 Cr ₹361.52 Cr ₹407.58 Cr
Total Expenses ₹1,492.76 Cr ₹1,597.85 Cr ₹1,507.13 Cr ₹1,280.71 Cr ₹1,071.74 Cr ₹1,105.7 Cr ₹1,067.87 Cr
Profit Before Exceptional Items & Tax -₹17.57 Cr ₹178.68 Cr -₹34.57 Cr -₹166.43 Cr -₹86.75 Cr ₹65.65 Cr -₹63.81 Cr
Exceptional Items ₹226.98 Cr ₹4 Cr -₹57.61 Cr -₹112.66 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹209.41 Cr ₹182.68 Cr -₹92.18 Cr -₹279.09 Cr -₹86.75 Cr ₹65.65 Cr -₹63.81 Cr
Total Tax Expense ₹50.47 Cr ₹19.72 Cr ₹0 ₹20.61 Cr -₹31.32 Cr ₹11.56 Cr -₹7.5 Cr
Net Profit ₹158.94 Cr ₹162.96 Cr -₹92.18 Cr -₹299.7 Cr -₹55.43 Cr ₹54.08 Cr -₹56.32 Cr
Other Comprehensive Income ₹7.6 Cr ₹10 Lakh -₹52.75 Lakh ₹38.73 Cr ₹55.37 Cr ₹21.3 Cr ₹3 Cr
Total Comprehensive Income ₹166.54 Cr ₹163.06 Cr -₹92.71 Cr -₹260.98 Cr -₹5.76 Lakh ₹75.39 Cr -₹53.32 Cr
EBITDA (computed) ₹113.26 Cr ₹294.71 Cr ₹81.31 Cr -₹51.07 Cr -₹1.49 Cr ₹142.84 Cr ₹8.56 Cr
Basic EPS ₹22.57 ₹23.15 ₹-13.09 ₹-42.57 ₹-7.87 ₹7.68 ₹-8.00
Diluted EPS ₹22.53 ₹23.08 ₹-13.09 ₹-42.57 ₹-7.87 ₹7.68 ₹-8.00
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹3,092.45 Cr ₹3,109.21 Cr ₹2,863.7 Cr ₹2,886.14 Cr
Non-current Assets ₹1,555.55 Cr ₹1,533.35 Cr ₹1,454.22 Cr ₹1,589.96 Cr
Current Assets ₹1,533.65 Cr ₹1,566.34 Cr ₹1,406.13 Cr ₹1,292.76 Cr
Property, Plant & Equipment ₹1,182.15 Cr ₹1,255.99 Cr ₹1,164.94 Cr ₹1,235.94 Cr
Inventories ₹592.48 Cr ₹584.06 Cr ₹500.53 Cr ₹480.19 Cr
Trade Receivables ₹582.94 Cr ₹748.14 Cr ₹558.42 Cr ₹472.08 Cr
Cash & Equivalents ₹252.67 Cr ₹60.58 Cr ₹125.65 Cr ₹155.67 Cr
Equity (Net Worth) ₹2,627.1 Cr ₹2,459.75 Cr ₹2,294.63 Cr ₹2,384.27 Cr
Equity Share Capital ₹14.08 Cr ₹14.08 Cr ₹14.08 Cr ₹14.08 Cr
Borrowings (Non-current) ₹39.12 Cr ₹60.81 Cr ₹38.22 Cr ₹63.65 Cr
Borrowings (Current) ₹14.22 Cr ₹50.24 Cr ₹25.66 Cr ₹38.03 Cr
Total Debt (computed) ₹53.34 Cr ₹111.05 Cr ₹63.89 Cr ₹101.68 Cr
Current Liabilities ₹314.96 Cr ₹519.53 Cr ₹487.94 Cr ₹388.66 Cr
Total Liabilities ₹465.35 Cr ₹649.46 Cr ₹569.07 Cr ₹501.87 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹52.6 Cr ₹72.29 Cr -₹41.57 Cr -₹117.33 Cr -₹158.31 Cr
Investing Cash Flow ₹207.81 Cr -₹132.07 Cr ₹53.24 Cr ₹202.5 Cr ₹104.03 Cr
Financing Cash Flow -₹70.66 Cr -₹4.61 Cr -₹48.06 Cr -₹61.76 Cr ₹95.8 Cr
Capital Expenditure ₹118.6 Cr ₹112.81 Cr ₹20.37 Cr ₹42.05 Cr ₹126.56 Cr
Free Cash Flow (computed) -₹66 Cr -₹40.52 Cr -₹61.94 Cr -₹159.38 Cr -₹284.87 Cr
Dividends Paid ₹36 Lakh ₹36 Lakh ₹21.35 Lakh ₹28.25 Cr ₹28.36 Cr
Net Change in Cash ₹192.09 Cr -₹65.07 Cr -₹30.02 Cr ₹25.16 Cr ₹41.53 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹356.24 Cr ₹314.9 Cr ₹356.9 Cr ₹384.25 Cr ₹461.24 Cr ₹447.83 Cr ₹436.88 Cr ₹389.75 Cr ₹399.24 Cr ₹362.43 Cr ₹333.83 Cr ₹346.67 Cr
Other Income ₹22.22 Cr ₹15.03 Cr ₹21.4 Cr ₹4.25 Cr ₹6.05 Cr ₹18.93 Cr ₹7.08 Cr ₹8.77 Cr ₹7.04 Cr ₹9.94 Cr ₹7.58 Cr ₹5.83 Cr
Total Income ₹378.46 Cr ₹329.93 Cr ₹378.3 Cr ₹388.5 Cr ₹467.29 Cr ₹466.76 Cr ₹443.96 Cr ₹398.52 Cr ₹406.28 Cr ₹372.37 Cr ₹341.41 Cr ₹352.49 Cr
Cost of Materials Consumed ₹149.98 Cr ₹152.42 Cr ₹165.31 Cr ₹203.88 Cr ₹220.8 Cr ₹193.01 Cr ₹215.64 Cr ₹200.32 Cr ₹189.37 Cr ₹188.69 Cr ₹166.88 Cr ₹171.98 Cr
Purchases of Stock-in-Trade ₹23 Lakh ₹23 Lakh ₹47 Lakh ₹12 Lakh ₹18 Lakh ₹18 Lakh ₹21 Lakh ₹27.95 Lakh ₹21.21 Lakh ₹21.28 Lakh ₹24.22 Lakh ₹24.38 Lakh
Changes in Inventories ₹12.1 Cr -₹4.21 Cr ₹6.91 Cr -₹22.08 Cr ₹1.88 Cr ₹3.11 Cr -₹12.68 Cr -₹25.64 Cr -₹2.12 Cr -₹14.95 Cr -₹4.84 Cr -₹4.44 Cr
Employee Benefit Expense ₹64.64 Cr ₹69.88 Cr ₹72.88 Cr ₹72.86 Cr ₹70.08 Cr ₹73.04 Cr ₹71.92 Cr ₹72.47 Cr ₹68.3 Cr ₹71.16 Cr ₹70.07 Cr ₹73.61 Cr
Finance Costs ₹4.09 Cr ₹2.1 Cr ₹3.68 Cr ₹1.93 Cr ₹1.53 Cr ₹2.89 Cr ₹1.82 Cr ₹1.38 Cr ₹1.76 Cr ₹2.36 Cr ₹3.82 Cr ₹2.48 Cr
Depreciation & Amortisation ₹28.97 Cr ₹30.02 Cr ₹30.11 Cr ₹29.93 Cr ₹27.47 Cr ₹28.45 Cr ₹26.39 Cr ₹26.11 Cr ₹25.22 Cr ₹25.62 Cr ₹27.26 Cr ₹27.36 Cr
Other Expenses ₹116.8 Cr ₹95.19 Cr ₹103.63 Cr ₹103.73 Cr ₹93.32 Cr ₹104.28 Cr ₹97.29 Cr ₹102.13 Cr ₹112.88 Cr ₹98 Cr ₹108.79 Cr ₹96.96 Cr
Total Expenses ₹376.81 Cr ₹345.63 Cr ₹382.99 Cr ₹390.37 Cr ₹415.26 Cr ₹404.96 Cr ₹400.59 Cr ₹377.04 Cr ₹395.63 Cr ₹371.08 Cr ₹372.22 Cr ₹368.2 Cr
Profit Before Exceptional Items & Tax ₹1.65 Cr -₹15.7 Cr -₹4.69 Cr -₹1.87 Cr ₹52.03 Cr ₹61.8 Cr ₹43.37 Cr ₹21.48 Cr ₹10.65 Cr ₹1.29 Cr -₹30.81 Cr -₹15.7 Cr
Exceptional Items -₹12.36 Cr ₹275.52 Cr -₹33.14 Cr ₹0 ₹4 Cr ₹0 ₹0 ₹0 -₹125.62 Cr ₹68.01 Cr ₹0 ₹0
Profit Before Tax -₹10.71 Cr ₹259.82 Cr -₹37.83 Cr -₹1.87 Cr ₹56.03 Cr ₹61.8 Cr ₹43.37 Cr ₹21.48 Cr -₹114.97 Cr ₹69.3 Cr -₹30.81 Cr -₹15.7 Cr
Total Tax Expense ₹4.68 Cr ₹43.71 Cr ₹2.1 Cr -₹2 Lakh ₹4.81 Cr ₹14.91 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Net Profit -₹15.39 Cr ₹216.11 Cr -₹39.93 Cr -₹1.85 Cr ₹51.22 Cr ₹46.89 Cr ₹43.37 Cr ₹21.48 Cr -₹114.97 Cr ₹69.3 Cr -₹30.81 Cr -₹15.7 Cr
Other Comprehensive Income ₹2.65 Cr ₹45 Lakh ₹82 Lakh ₹3.68 Cr ₹1.41 Cr -₹1.11 Cr -₹80 Lakh ₹60.38 Lakh ₹44.83 Lakh ₹32.5 Lakh -₹1.12 Cr -₹17.87 Lakh
Total Comprehensive Income -₹12.74 Cr ₹216.56 Cr -₹39.11 Cr ₹1.83 Cr ₹52.63 Cr ₹45.78 Cr ₹42.57 Cr ₹22.09 Cr -₹114.52 Cr ₹69.63 Cr -₹31.93 Cr -₹15.88 Cr
EBITDA (computed) ₹34.71 Cr ₹16.42 Cr ₹29.1 Cr ₹29.99 Cr ₹81.03 Cr ₹93.14 Cr ₹71.58 Cr ₹48.97 Cr ₹37.63 Cr ₹29.26 Cr ₹27.45 Lakh ₹14.14 Cr
Basic EPS ₹-2.19 ₹30.69 ₹-5.67 ₹-0.26 ₹7.28 ₹6.66 ₹6.16 ₹3.05 ₹-16.33 ₹9.85 ₹-4.38 ₹-2.23
Diluted EPS ₹-2.19 ₹30.64 ₹-5.67 ₹-0.26 ₹7.26 ₹6.63 ₹6.15 ₹3.04 ₹-16.33 ₹9.85 ₹-4.38 ₹-2.23
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Unichem Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Unichem Laboratories Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 70.22%, foreign institutional investors hold 1.00%, domestic institutional investors hold 10.63%, retail and other public shareholders hold 18.15% of Unichem Laboratories Limited. The company had 23,386 shareholders on record.

Promoters: 70.22%DII (Domestic Institutional): 10.63%FII (Foreign Institutional): 1.00%Retail & Others: 18.15%
Mar 2026
QUARTER
70.22% Promoters
10.63% DII (Domestic Institutional)
1.00% FII (Foreign Institutional)
18.15% Retail & Others
Promoter holding - history
Now 70.22% · Mar 2026High 70.22% · Dec 2023Low 50.05% · Dec 2017
49%54.8%60.5%66.3%72%Dec 2015Jun 2018Dec 2020Jun 2023Dec 2025Dec 2015: 50.11%Mar 2016: 50.10%Jun 2016: 50.09%Sep 2016: 50.08%Dec 2016: 50.08%Mar 2017: 50.08%Jun 2017: 50.06%Sep 2017: 50.06%Dec 2017: 50.05%Mar 2018: 50.67%Jun 2018: 50.67%Sep 2018: 50.67%Dec 2018: 50.64%Mar 2019: 50.64%Jun 2019: 50.62%Sep 2019: 50.62%Dec 2019: 50.62%Mar 2020: 50.74%Jun 2020: 50.93%Sep 2020: 50.93%Dec 2020: 50.93%Mar 2021: 50.93%Jun 2021: 50.93%Sep 2021: 50.93%Dec 2021: 50.93%Mar 2022: 50.93%Jun 2022: 50.93%Sep 2022: 50.93%Dec 2022: 50.93%Mar 2023: 50.93%Jun 2023: 50.93%Sep 2023: 70.21%Dec 2023: 70.22%Mar 2024: 70.22%Jun 2024: 70.22%Sep 2024: 70.22%Dec 2024: 70.22%Mar 2025: 70.22%Jun 2025: 70.22%Sep 2025: 70.22%Dec 2025: 70.22%Mar 2026: 70.22%70.22%50.05%70.22%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters70.22%70.22%70.22%70.22%70.22%70.22%
Public29.78%29.78%29.78%29.78%29.78%29.78%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters70.22%70.22%70.22%50.93%50.93%50.93%50.74%50.64%50.67%50.08%50.10%
Public29.78%29.78%29.78%49.07%49.07%49.07%49.26%49.36%49.33%49.92%49.90%
Promoter change (YoY, %pts)+0.00+0.00+19.29+0.00+0.00+0.19+0.10-0.03+0.59-0.02-

Board & Governance of Unichem Laboratories Limited

As per the corporate governance filing with NSE for the quarter ended 31-DEC-2025, the board of Unichem Laboratories Limited has 6 directors - 3 independent and 1 executive. The board is chaired by Mody Prakash Amrut.

DirectorPositionOn board sinceListed boards
Mody Prakash Amrut Non-Executive - Non Independent Director · Chairperson 1974-06-22 1
Pranay Godha Non-Executive - Non Independent Director 2023-08-10 2
Pabitrakumar Kalipada Bhattacharyya Executive Director 2023-08-10 2
Priti Puri Non-Executive - Independent Director 2023-03-21 1
Arun Lalchand Todarwal Non-Executive - Independent Director 2024-02-05 4
Anand Trimbak Kurse Non-Executive - Independent Director 2024-02-05 1
Board Committees
CommitteeMembers
Audit Committee Arun Lalchand Todarwal (Chairperson), Pabitrakumar Kalipada Bhattacharyya, Anand Trimbak Kurse, Priti Puri
Nomination and remuneration committee Arun Lalchand Todarwal (Chairperson), Anand Trimbak Kurse, Priti Puri
Stakeholders Relationship Committee Anand Trimbak Kurse (Chairperson), Pranay Godha, Pabitrakumar Kalipada Bhattacharyya, Priti Puri
Risk Management Committee Arun Lalchand Todarwal (Chairperson), Pranay Godha, Pabitrakumar Kalipada Bhattacharyya, Anand Trimbak Kurse
Corporate Social Responsibility Committee Arun Lalchand Todarwal (Chairperson), Pranay Godha, Pabitrakumar Kalipada Bhattacharyya

Group Structure of Unichem Laboratories Limited

Unichem Laboratories Limited has 1 associated company. This group structure data is as of FY 2025. The corporate group structure reflects Unichem Laboratories Limited's business expansion strategy and organizational complexity.

1
Associated companies

Charges & Borrowings of Unichem Laboratories Limited

Open charges
₹236 Cr
Satisfied charges
₹249.07 Cr
Breakdown by lending institutions
Others₹155.00 Cr
Citi Bank N.A.₹81.00 Cr
Latest charge details
DateLenderAmountStatus
20 Jun 2025 Citi Bank N.A. ₹30 Cr Open
24 Jan 2025 Citi Bank N.A. ₹51 Cr Open
04 Jan 2022 Others ₹30 Cr Open
31 May 2019 Others ₹125 Cr Open
28 Feb 2020 Axis Bank Limited ₹30 Cr Satisfied

Total charge records: 54 View all charges

Employees and EPFO Compliance at Unichem Laboratories Limited

Unichem Laboratories Limited has a workforce of 3,635 employees as of Sep 25, 2025.

Employee count
3,635
Active EPFO establishments
8
Employee growth
4.91%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Unichem Laboratories Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Unichem Laboratories Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Unichem Laboratories Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Unichem Laboratories Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Unichem Laboratories Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Unichem Laboratories Limited

MSME Payment Delays by Unichem Laboratories Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Unichem Laboratories Limited

Subsidiaries & Group Companies of Unichem Laboratories Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Unichem Laboratories Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Unichem Laboratories Limited

MCA Filings & Documents of Unichem Laboratories Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Unichem Laboratories Limited

Directors
05 Feb 2026
Swati Arvind Patankar was appointed as a Additional Director on 05 Feb 2026 & has been associated with this company since 5 months 3 days.
Charges
14 Jan 2026
A charge with Others of Rs. 125.00 Cr registered on 31 May 2019 with Charge ID 100269504 was modified on 14 Jan 2026.
Activity
04 Aug 2025
Unichem Laboratories Limited last Annual general meeting of members was held on 04 Aug 2025 as per latest MCA records.
Charges
17 Jul 2025
A charge registered on 28 Feb 2020 via Charge ID 100327424 with Axis Bank Limited was fully satisfied on 17 Jul 2025.
Charges
20 Jun 2025
A charge with Citi Bank N.A. amounted to Rs. 30.00 Cr with Charge ID 101119422 was registered on 20 Jun 2025.
Activity
31 Mar 2025
Unichem Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.

Recent News on Unichem Laboratories Limited

Stocks that will see action today: March 21, 2025
21 Mar 2025 · Thehindubusinessline

Frequently Asked Questions about Unichem Laboratories Limited

Unichem Laboratories Limited is an active public limited company in the pharma sector based in Kandivali West, Maharashtra, India. It was incorporated on 22 August 1962 (64+ years old) and is registered under CIN L99999MH1962PLC012451. Listed on BSE: 506690 and NSE: UNICHEMLAB. The company has 3,635 employees.

Unichem Laboratories Limited reported revenue of ₹2,146.29 Cr for FY 2025 (up 18.00% YoY).

The current directors of Unichem Laboratories Limited are:

The primary industry of Unichem Laboratories Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Unichem Laboratories Limited is listed on both BSE (code: 506690) and NSE (symbol: UNICHEMLAB).

Unichem Laboratories Limited can be reached at the registered office: 47 Kandivli Industrial Estate, Kandivali West, Maharashtra, India – 400067, or through the website unichemlabs.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available